证券集体诉讼领域最受信赖的律所

过去两年,为投资者追回超过 4 亿美元资金

Arhaus, Inc.

On April 29, 2024, after market hours, Arhaus filed a Current Report on Form 8-K with the Securities and Exchange Commission (“SEC”) announcing “the Company’s

Read More

Malibu Boats, Inc.

According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: Malibu Boats engaged in an “elaborate

Read More

EQUINIX, INC.

According to the lawsuit, throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: Equinix manipulated its financials to reduce

Read More

Akero Therapeutics, Inc.

According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: approximately 20% of the patients enrolled

Read More

Exscientia plc

According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: defendant Andrew Hopkins (“Hopkins”) had engaged

Read More

Lincoln National Corporation

According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: Lincoln National was experiencing a decline

Read More

Harbor Diversified, Inc.

On March 29, 2024, Harbor Diversified filed a current report on Form 8-K with the U.S. Securities and Exchange Commission. In this current report, Harbor

Read More

Cidara Therapeutics, Inc.

On April 16, 2024, Cidara Therapeutics filed a current report on Form 8-K with the SEC. In this 8-K, Cidara Therapeutics announced that it’s “previously

Read More

Arhaus, Inc.

On April 29, 2024, after market hours, Arhaus filed a Current Report on Form 8-K with the Securities and Exchange Commission (“SEC”) announcing “the Company’s

Read More

Malibu Boats, Inc.

According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: Malibu Boats engaged in an “elaborate

Read More

EQUINIX, INC.

According to the lawsuit, throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: Equinix manipulated its financials to reduce

Read More

Akero Therapeutics, Inc.

According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: approximately 20% of the patients enrolled

Read More

Exscientia plc

According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: defendant Andrew Hopkins (“Hopkins”) had engaged

Read More

Lincoln National Corporation

According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: Lincoln National was experiencing a decline

Read More

Harbor Diversified, Inc.

On March 29, 2024, Harbor Diversified filed a current report on Form 8-K with the U.S. Securities and Exchange Commission. In this current report, Harbor

Read More

Cidara Therapeutics, Inc.

On April 16, 2024, Cidara Therapeutics filed a current report on Form 8-K with the SEC. In this 8-K, Cidara Therapeutics announced that it’s “previously

Read More

GoodRx Holdings, Inc.

According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: while Kroger accounted for less than

Read More

Global Cord Blood Corporation

According to the lawsuit, defendants made false and/or misleading statements and/or failed to disclose that: Global Cord employed a capital allocation strategy designed to reserve

Read More

Autodesk, Inc.

According to the lawsuit, throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: Autodesk, Inc. lacked adequate internal controls

Read More

Sharecare, Inc.

According to the lawsuit, throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: Sharecare lacked adequate internal controls; and

Read More

AST SpaceMobile, Inc.

According to the lawsuit, defendants made false and/or misleading statements and/or failed to disclose that: production of AST Spacemobile’s five Block 1 BlueBird satellites had

Read More

我们的办公室

New York

275 Madison Avenue,

40th Floor
New York, NY 10016
T: 212.686.1060
F: 212.202.3827

Los Angeles

355 South Grand Avenue, Suite 2450
Los Angeles, CA 90071
T: 213.785.2610
F: 213.226.4684

Philadelphia Metro

101 Greenwood Avenue,

Suite 440
Jenkintown, PA 19046
T: 215.600.2817

New Jersey

One Gateway Center,

Suite 2600
Newark, NJ 07102
T: 973.313.1887
F: 973.833.0399

我们的使命

罗森律师事务所专门为因公司欺诈和其他不当行为遭受损失的受害股东追偿损失。我们的律师在处理复杂金融诉讼以及为客户赢得重大胜利与和解方面,拥有丰富的知识和经验。作为知名的原告代理律师事务所,我们专注于证券集体诉讼和股东派生诉讼,是并且已经为我们的客户追回总计数亿美元的损害赔偿金。我们的使命是保护股东的权利。

新闻动态

常见问题

集体诉讼是指其中一名或多名投资者作为原告代表,代表一大批投资者进行的诉讼,这一大批投资者购买了相同证券,并均因同一虚假陈述或不当行为而蒙受损失。  集体诉讼允许法院在一件诉讼中就许多投资者的索赔作出判决。这是一种高效、经济的诉讼形式,它将司法正义延伸至那些索赔额不高而不值得提起个人诉讼的投资者身上。

是指投资者购买集体诉讼中 被起诉的公司的证券的时间段。  通常,虚假陈述或欺诈在集体诉讼期第一天开始,而关于虚假陈述或欺诈的完整真相在集体诉讼期最后一天披露。

首席原告是指希望在集体诉讼中,代表在集体诉讼期购买证券的所有其他投资者的原告。

首席原告的职责是在集体诉讼律师的协助和建议下监督诉讼。首席原告和集体诉讼律师都必须以集体利益为出发点来引导诉讼。最终,首席原告需要决定集体诉讼的和解金的合理数额并批准和解要约。

首席律师是指代表投资人集体的律师。  首席原告选择首席律师。  如果首席律师要在证券集体诉讼中有效代理投资者,其应拥有丰富的证券集体诉讼的经验。

如果您的投资损失金额对您而言巨大,担任首席原告可帮助您参与集体诉讼,监督诉讼中的重要决策,尤其是投资者和解金额。集体诉讼通常是在每个受害者提起个人诉讼不切实际或代价高昂的情况下提起的,集体诉讼可帮助小股东或消费者向拥有更多法律和财务资源的大公司追讨损失。通常,证券集体诉讼在联邦地区法院提起,指控被告违反《1933 年证券法》和/或《1934 年证券交易法》的反欺诈规定。集体诉讼通常需要至少2-3 年时间,但具体到每一个案件来说,所需的时间因案件复杂性、涉案问题和其他因素而异。

您可以在我们的网站上填写在线认证表格,或者根据您的要求,我们通过电子邮件向您发送表格,您填写完毕后将表格返回给我们。

您无需支付任何律师费、费用和支出。法院将从首席律师为集体追回的资金中,给予其任何律师费、费用或支出。如果首席律师未能为集体追回任何资金,则首席律师不会获得任何律师费、费用或支出。

免费咨询

罗森律师事务所专门为投资者追回投资损失,这些投资者所投资的公司在其业务实质方面存在虚假陈述,或其高级管理人员和董事违反对股东的信义义务。

滚动至顶部